Hosted on MSN

Innospec outlines margin improvement focus and expects operating income growth in 2026 despite Q1 weather impact

Patrick Williams, President and CEO, stated that "this was a good quarter for Innospec with continued strong operating income growth and margin expansion in Fuel Specialties, combined with improving ...
Seeking Alpha

Corteva outlines $4.1B 2026 operating EBITDA target as separation and licensing strategy accelerate growth

CEO Charles Magro highlighted that Corteva remains on track for a second half separation, most likely in the fourth quarter, and expects to announce the new CEO and SpinCo brand identity in the first ...
Hosted on MSN

Cencora outlines 11.5%-13.5% operating income growth for 2026 while integrating OneOncology

CEO Robert Mauch announced the completion of the acquisition of the majority of the remaining equity interest in OneOncology, emphasizing, "we are raising our fiscal 2026 guidance to reflect year-over ...
Seeking Alpha

Fresenius Medical Care delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target band

yoy = year-on-year, cc = at constant currency, EPS = earnings per share Click to enlarge FME Reignite set for next phase of value creation Fresenius Medical Care, the world's leading provider of ...
The Motley Fool

Meta Stock Slips Below $600. Time to Buy?

The company is leaning into a highly capital-intensive cycle to fund its artificial intelligence initiatives. Meta's fourth-quarter operating income growth trailed its revenue growth. The social media ...